PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Penn, Marc S.
TI  - Stem Cell Promotor JVS-100 Appears Safe and Shows Promising Trends in HF after MI
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 22--23
VI  - 14
IP  - 12
4099  - http://mdc.sagepub.com/content/14/12/22.short
4100  - http://mdc.sagepub.com/content/14/12/22.full
AB  - Patients with heart failure (HF) and previous myocardial infarctions (MIs) demonstrated favorable outcomes after treatment with JVS-100, a plasmid that encodes for stromal cell—derived factor-1. This article presents data from the Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure trial [STOP-HF; NCT01643590].